Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents And Short-Term Investments

v2.3.0.15
Cash, Cash Equivalents And Short-Term Investments
9 Months Ended
Oct. 31, 2011
Cash, Cash Equivalents And Short-Term Investments [Abstract]  
Cash, Cash Equivalents And Short-Term Investments
2.   Cash, Cash Equivalents and Short-term Investments

Cash, cash equivalents and short-term investments consisted of the following:

 

     As of
January 31,
2011
     As of
October 31,
2011
 
     (in thousands)  

Cash and cash equivalents:

     

Cash

   $ 4,974       $ 4,813   

Money market funds

     38,074         35,888   

Commercial paper

     —           8,499   

Corporate debt securities

     —           4,676   
  

 

 

    

 

 

 

Total cash and cash equivalents

   $ 43,048       $ 53,876   
  

 

 

    

 

 

 

Short-term investments:

     

Commercial paper

   $ —         $ 22,438   

Corporate debt securities

     —           13,585   

U.S. agency notes

     —           900   
  

 

 

    

 

 

 

Total short-term investments

   $ —         $ 36,923   
  

 

 

    

 

 

 

Cash, cash equivalents and short-term investments

   $ 43,048       $ 90,799   
  

 

 

    

 

 

 

The Company's short-term investments have maturities of less than 12 months and are classified as available for sale. As of January 31 and October 31, 2011 the cost basis of the Company's cash and cash equivalents approximated their fair values and as a result, no unrealized gains or losses were recorded as of January 31 and October 31, 2011.

The following table summarizes the Company's available-for-sale securities' adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of October 31, 2011 (in thousands). No such investments were held as of January 31, 2011.

 

     As of October 31, 2011  
     Adjusted
Cost
     Unrealized
Gains
     Unrealized
Losses
    Fair
Value
 

Cash equivalents and marketable securities:

          

Money market funds

   $ 35,888       $ —         $ —        $ 35,888   

Commercial paper

     30,940         3         (6     30,937   

Corporate debt securities

     18,269         —           (8     18,261   

U.S. agency notes

     900         —           —          900   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total cash equivalents and marketable securities

   $ 85,997       $ 3       $ (14   $ 85,986   
  

 

 

    

 

 

    

 

 

   

 

 

 

The Company's investment policy requires investments to be investment grade, primarily rated "A1" by Standard & Poor's or "P1" by Moody's or better for short-term investments, with the objective of minimizing the potential risk of principal loss. In addition, the investment policy limits the amount of credit exposure to any one issuer.

 

The following tables show the gross unrealized losses and the fair value of those available-for-sale securities that were in an unrealized loss position (in thousands):

 

     As of October 31, 2011  
     Fair Value       Gross Unrealized
Losses
 

Commercial paper

   $  16,989       $ (6

Corporate debt securities

     12,217       $ (8
  

 

 

    

 

 

 

Total

   $ 29,206       $ (14

The unrealized losses on our available-for-sale securities were primarily a result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. As of October 31, 2011, the Company owned 21 securities that were in an unrealized loss position. The Company does not intend nor expect to need to sell these securities before recovering the associated unrealized losses. It expects to recover the full carrying value of these securities. As a result, no portion of the unrealized losses at October 31, 2011 is deemed to be other-than-temporary and the unrealized losses are not deemed to be credit losses. No available-for-sale securities have been in an unrealized loss position for 12 months or more. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company's intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment's amortized cost basis. During the three and nine months ended October 31, 2011, the Company did not recognize any impairment charges.